← back to search

Sreenivas Nannapaneni

GlaxoSmithKline (United States) · US
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cell Adhesion Molecules Research, and Head and Neck Cancer Studies.
h-index
19
citations
1,312
works
142
NIH funding
primary concept
email

Recent publications

Combination of resveratrol and green tea epigallocatechin gallate induces synergistic apoptosis and inhibits tumor growth <i>in vivo</i> in head and neck cancer models
Oncology Reports 2021cited by 35position: middledoi
A Correlative Analysis of PD-L1, PD-1, PD-L2, EGFR, HER2, and HER3 Expression in Oropharyngeal Squamous Cell Carcinoma
Molecular Cancer Therapeutics 2018cited by 29position: middledoi
Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth
Angewandte Chemie International Edition 2017cited by 132position: middledoi
HER3 Targeting Sensitizes HNSCC to Cetuximab by Reducing HER3 Activity and HER2/HER3 Dimerization: Evidence from Cell Line and Patient-Derived Xenograft Models
Clinical Cancer Research 2016cited by 72position: middledoi
Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation
European Journal of Cancer 2016cited by 26position: middledoi
Luteolin Nanoparticle in Chemoprevention: <i>In Vitro</i> and <i>In Vivo</i> Anticancer Activity
Cancer Prevention Research 2014cited by 163position: middledoi
Combination of Anti-HER3 Antibody MM-121/SAR256212 and Cetuximab Inhibits Tumor Growth in Preclinical Models of Head and Neck Squamous Cell Carcinoma
Molecular Cancer Therapeutics 2014cited by 60position: middledoi
Honokiol Enhances Paclitaxel Efficacy in Multi-Drug Resistant Human Cancer Model through the Induction of Apoptosis
PLoS ONE 2014cited by 50position: middledoi
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
Clinical Cancer Research 2013cited by 135position: middledoi
Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study
Cancer Prevention Research 2013cited by 74position: middledoi
Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical Studies
Clinical Cancer Research 2013cited by 60position: middledoi
Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth
Journal of Controlled Release 2012cited by 87position: middledoi
The Pivotal Role of Integrin β1 in Metastasis of Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research 2012cited by 46position: middledoi
Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer
European Journal of Cancer 2012cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dong M. Shin · Emory Healthcare13 papers (2012–2018)Zhengjia Chen · University of Illinois Chicago11 papers (2012–2017)A.R.M. Ruhul Amin · Marshall University9 papers (2012–2021)Zhuo Georgia Chen · Woodruff Health Sciences Center8 papers (2012–2018)Dongsheng Wang · Qingdao University7 papers (2012–2021)Nabil F. Saba · Emory University7 papers (2012–2018)Mohammad Aminur Rahman · University of Southern Queensland5 papers (2012–2017)Hyung Ju C. Shin · Quest Diagnostics (United States)4 papers (2013–2014)Lydia Koenig · Mayo Clinic in Arizona4 papers (2012–2014)Jonathan J. Beitler · St. Louis VA Medical Center4 papers (2012–2014)Fadlo R. Khuri · Emory University4 papers (2013–2016)Hongzheng Zhang · Zhujiang Hospital4 papers (2013–2016)Zhongliang Hu · Central South University3 papers (2012–2016)Susan Müller · Emory University3 papers (2012–2013)Guoqing Qian · Ningbo University Affiliated Hospital3 papers (2014–2016)Kelly R. Magliocca · Emory University3 papers (2016–2018)Christopher Griffith · Cleveland Clinic2 papers (2017–2018)Selwyn J. Hurwitz · Emory University2 papers (2013–2017)Rachel Moreno-Williams · Quest Diagnostics (United States)2 papers (2013–2013)Taofeek K. Owonikoko · New Mexico Cancer Center2 papers (2013–2018)